167 related articles for article (PubMed ID: 29340043)
1. Clinical significance of YAP1 activation in head and neck squamous cell carcinoma.
Eun YG; Lee D; Lee YC; Sohn BH; Kim EH; Yim SY; Kwon KH; Lee JS
Oncotarget; 2017 Dec; 8(67):111130-111143. PubMed ID: 29340043
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of CUB and Sushi Multiple Domains 1 Inactivation in Head and Neck Squamous Cell Carcinoma.
Jung AR; Eun YG; Lee YC; Noh JK; Kwon KH
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545040
[TBL] [Abstract][Full Text] [Related]
4. Verteporfin suppresses the proliferation, epithelial-mesenchymal transition and stemness of head and neck squamous carcinoma cells via inhibiting YAP1.
Liu K; Du S; Gao P; Zheng J
J Cancer; 2019; 10(18):4196-4207. PubMed ID: 31413738
[No Abstract] [Full Text] [Related]
5. SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma.
Chung JH; Jung HR; Jung AR; Lee YC; Kong M; Lee JS; Eun YG
Sci Rep; 2018 Jan; 8(1):1677. PubMed ID: 29374236
[TBL] [Abstract][Full Text] [Related]
6. Molecular landscape of head and neck cancer and implications for therapy.
Farah CS
Ann Transl Med; 2021 May; 9(10):915. PubMed ID: 34164549
[TBL] [Abstract][Full Text] [Related]
7. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
Solomon B; Young RJ; Rischin D
Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
[TBL] [Abstract][Full Text] [Related]
9. SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.
Ozawa H; Ranaweera RS; Izumchenko E; Makarev E; Zhavoronkov A; Fertig EJ; Howard JD; Markovic A; Bedi A; Ravi R; Perez J; Le QT; Kong CS; Jordan RC; Wang H; Kang H; Quon H; Sidransky D; Chung CH
Clin Cancer Res; 2017 Sep; 23(17):5162-5175. PubMed ID: 28522603
[No Abstract] [Full Text] [Related]
10. Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Cheng H; Yang X; Si H; Saleh AD; Xiao W; Coupar J; Gollin SM; Ferris RL; Issaeva N; Yarbrough WG; Prince ME; Carey TE; Van Waes C; Chen Z
Cell Rep; 2018 Oct; 25(5):1332-1345.e5. PubMed ID: 30380422
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas.
Szabó B; Nelhubel GA; Kárpáti A; Kenessey I; Jóri B; Székely C; Peták I; Lotz G; Hegedus Z; Hegedus B; Füle T; Döme B; Tímár J; Tóvári J
Oral Oncol; 2011 Jun; 47(6):487-96. PubMed ID: 21498106
[TBL] [Abstract][Full Text] [Related]
12. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
[TBL] [Abstract][Full Text] [Related]
13. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
14. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
[TBL] [Abstract][Full Text] [Related]
15. The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.
Fukusumi T; Califano JA
J Dent Res; 2018 Jun; 97(6):645-653. PubMed ID: 29489439
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
17. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.
Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C
Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Genomic Review of TCGA Head and Neck Squamous Cell Carcinomas (HNSCC).
Pérez Sayáns M; Chamorro Petronacci CM; Lorenzo Pouso AI; Padín Iruegas E; Blanco Carrión A; Suárez Peñaranda JM; García García A
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31703248
[TBL] [Abstract][Full Text] [Related]
19. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
20. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.
Wu ES; Park JY; Zeitouni JA; Gomez CR; Reis IM; Zhao W; Kwon D; Lee E; Nelson OL; Lin HY; Franzmann EJ; Savell J; McCaffrey TV; Goodwin WJ; Hu JJ
Head Neck; 2016 Aug; 38(8):1234-41. PubMed ID: 27028310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]